Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01987063
Other study ID # NI12012
Secondary ID
Status Completed
Phase N/A
First received November 4, 2013
Last updated April 18, 2016
Start date February 2014
Est. completion date December 2015

Study information

Verified date April 2016
Source Assistance Publique - Hôpitaux de Paris
Contact n/a
Is FDA regulated No
Health authority France: Ministry of Health
Study type Observational

Clinical Trial Summary

The purpose of this study is to determine the best obstetrical practices for twin delivery.


Description:

Large retrospective cohort studies have reported increased neonatal death and morbidity associated with vaginal delivery in comparison with cesarean in twin pregnancies. A recent large international randomized trial, the Twin Birth Study (TBS), showed that planned cesarean does not significantly decrease or increase the risk of fetal or neonatal death or serious neonatal morbidity, as compared with planned vaginal delivery in twin pregnancy between 32 and 39 weeks of gestation with a first twin in cephalic presentation. However, neither these large retrospective cohort studies, because information regarding delivery management is lacking, nor the TBS, because of insufficient statistical power, can answer the question on how to manage vaginal twin deliveries.

The aim of the JUMODA study is first to confirm in France whether planned vaginal delivery is not associated with increased neonatal risks in comparison with planned caesarean as shown in the TBS and secondly to determine the best obstetrical practices in case of vaginal delivery.

Analysis will be performed according to the planned mode of delivery (planned cesarean or planned vaginal delivery) and stratified according to:

1. Twin rank: second or first twin

2. Gestational age: before 28 weeks of gestation, before 32 weeks, after 32 weeks, and after 35 weeks

3. In the whole population and in low risk populations.

For women delivering vaginally, analysis will be stratified according to:

4. Second twin presentation: vertex or non vertex

5. Obstetrical manoeuvres: none, internal cephalic version, external cephalic version, total breech extraction


Recruitment information / eligibility

Status Completed
Enrollment 8979
Est. completion date December 2015
Est. primary completion date June 2015
Accepts healthy volunteers No
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria:

- All patients delivering twins after 22 weeks and 0 days gestation in the participating maternities will be included in the study.

Exclusion Criteria:

- Patients who expressed opposition to the use of personal medical data or medical data from their children for this research will not be included in the study

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Locations

Country Name City State
France Hôpital Robert Debré - APHP Paris

Sponsors (1)

Lead Sponsor Collaborator
Assistance Publique - Hôpitaux de Paris

Country where clinical trial is conducted

France, 

References & Publications (4)

Barrett JF, Hannah ME, Hutton EK, Willan AR, Allen AC, Armson BA, Gafni A, Joseph KS, Mason D, Ohlsson A, Ross S, Sanchez JJ, Asztalos EV; Twin Birth Study Collaborative Group. A randomized trial of planned cesarean or vaginal delivery for twin pregnancy. N Engl J Med. 2013 Oct 3;369(14):1295-305. doi: 10.1056/NEJMoa1214939. Erratum in: N Engl J Med. 2013 Dec 12;369(24):2364. — View Citation

Smith GC, Pell JP, Dobbie R. Birth order, gestational age, and risk of delivery related perinatal death in twins: retrospective cohort study. BMJ. 2002 Nov 2;325(7371):1004. — View Citation

Smith GC, Shah I, White IR, Pell JP, Dobbie R. Mode of delivery and the risk of delivery-related perinatal death among twins at term: a retrospective cohort study of 8073 births. BJOG. 2005 Aug;112(8):1139-44. — View Citation

Smith GC. Perinatal death in twins. Author's reply on absolute risk. BMJ. 2007 Apr 14;334(7597):762. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Composite measure of intrapartum and neonatal death and serious morbidity of the second twin after 32 weeks 0 days of gestation Intrapartum fetal death
Neonatal mortality
Apgar score lower than 4 at 5 minutes
Neonatal trauma (fracture of long bones or skull, subdural hematoma, brachial plexus elongation, phrenic or facial paralysis, injury of the spinal cord
Abnormal level of consciousness (coma, stupor, abnormal response to pain)
Intubation longer than 24 hours within the first 72 hours of life, two or more episodes of neonatal convulsions in the first 72 hours of life
Proved neonatal infection
Bronchopulmonary dysplasia
Necrotizing enterocolitis
Intraventricular hemorrhage grade III or IV
Periventricular leukomalacia.
72 hours after birth No
Secondary Composite measure of intrapartum and neonatal death and serious morbidity of the first twin after 32 weeks 0 days of gestation Composite measure of intrapartum and neonatal death and serious morbidity of the first twin after 32 weeks 0 days of gestation Day 28 after birth No
Secondary Composite measure of intrapartum and neonatal death and serious morbidity of the second twin after 32 weeks 0 days of gestation Composite measure of intrapartum and neonatal death and serious morbidity of the second twin after 32 weeks 0 days of gestation Day 28 after birth No
Secondary Composite measure of maternal death and serious morbidity after 32 weeks 0 days of gestation Maternal death
Severe postpartum hemorrhage (PPH) defined as PPH requiring transfusion, embolisation, surgery, intensive care unit
Pulmonary embolism, deep venous thrombosis
Cerebrovascular accident
Postpartum psychosis
Severe thrombopenia (<50 000)
Severe anemia (<7g/dL)
Renal failure (oliguria <500 mL/24h or creatinin>135 mmol/L)
Maternal transfer in ICU
Laparotomy
Intraoperative injury to the bowel, ureter or bladder requiring repair
Vulvar or perineal hematoma requiring evacuation
Third and fourth degree perineal lacerations
Systemic infection (positive blood culture or temperature > 38.5 °C on two or more occasions at least 24h apart)
Weeks after birth and before hospital discharge No
Secondary Duration of neonatal hospitalisation of first twin Duration between birth and hospital discharge Weeks after birth and before hospital discharge No
Secondary Duration of neonatal hospitalisation of second twin Duration between birth and hospital discharge Weeks after birth and before hospital discharge No
Secondary Duration of maternal hospitalisation Duration between delivery and hospital discharge Weeks after birth and before hospital discharge No